Human Microbiome Market

Human Microbiome Market Segmentation, Size, Share, Trends, Growth, Value, Demand, and Company Profile Analysis Forecast Report 2021-2026 | COVID-19 Impact on the Global Market

1. Preface
1.1 Market Definition and Scope
1.2 Base Currency, Base Year and Forecast Periods
1.3 Key Research Objectives
1.4 Research Highlights
2. General Study Assumptions
3. Research Methodology
3.1 Introduction
3.2 Secondary Research
3.3 Primary Research
3.4 Analysis Design
3.5 Study Timeline
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Market Trends
5. Supply Chain Analysis
6. Company Strategy Analysis
6.1 Merger and Acquisition Analysis
6.2 Agreements, Collaborations and Joint Ventures
6.3 Regional Presence
6.4 New Product Launches
7. Market Outlook
7.1 Technological Advancement
7.2 Pricing Analysis
7.3 Epidemiology
7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)
8. Market Segmentation
8.1 Overview
8.2 Global Human Microbiome Market, By Product, forecast year 2021-2026
8.2.1 Prebiotics
8.2.2 Probiotics
8.2.3 Food
8.2.4 Diagnostic Tests
8.2.5 Drugs
8.2.6 Market Size Estimations & Forecasts (2021-2026)
8.2.7 Y-o-Y Growth Analysis
8.2.8 Market Investment Opportunities Analysis
8.3 Global Human Microbiome Market, By Application, forecast year 2021-2026
8.3.1 Therapeutic
8.3.2 Diagnostic
8.3.3 Market Size Estimations & Forecasts (2021-2026)
8.3.4 Y-o-Y Growth Analysis
8.3.5 Market Investment Opportunities Analysis
8.4 Global Human Microbiome Market, By Disease, forecast year 2021-2026
8.4.1 Infectious
8.4.2 Metabolic/Endocrine
8.4.3 Market Size Estimations & Forecasts (2021-2026)
8.4.4 Y-o-Y Growth Analysis
8.4.5 Market Investment Opportunities Analysis
8.5 Global Human Microbiome Market, By Research Technology, forecast year 2021-2026
8.5.1 Genomics
8.5.2 Proteomics
8.5.3 Metabolomics
8.5.4 Market Size Estimations & Forecasts (2021-2026)
8.5.5 Y-o-Y Growth Analysis
8.5.6 Market Investment Opportunities Analysis
9. Market Regional and Country Analysis, Forecast 2021-2026
9.1 Overview
9.2 Regional Trends
9.3 Impact Analysis
9.4 Key Findings
9.5 Global Human Microbiome Market, by Region, 2021-2026
9.5.1 By Product
9.5.2 By Application
9.5.3 By Disease
9.5.4 By Research Technology
10. Competitive Landscape Analysis
10.1 Market Player
10.1.1 Company Revenue
10.1.2 Business unit
10.1.3 Product Mapping
10.1.4 Geographical Locations
10.2 Company Share Analysis
11. Strategic Analysis
11.1 PESTLE analysis
11.2 Porter’s Five analysis
11.2.1 Bargaining Power of Suppliers
11.2.2 Bargaining Power of Consumers
11.2.3 Threat of New Entrants
11.2.4 Threat of Substitute Products and Services
11.2.5 Competitive Rivalry within the Industry
12. Company Profiles
12.1 ENTEROME
12.1.1 Overview
12.1.2 Product Portfolio
12.1.3 Financial Details
12.1.4 SWOT Analysis
12.1.5 Market Strategies
12.2 SERES THERAPEUTICS
12.3 4D PHARMA PLC
12.4 EVELO BIOSCIENCES, INC
12.5 OPTIBIOTIX HEALTH PLC
12.6 SYNLOGIC
12.7 SECOND GENOME
12.8 VEDANTA BIOSCIENCES, INC
12.9 FERRING PHARMACEUTICALS
12.10 VITHERA PHARMACEUTICALS, INC
13. Market Guidance
14. Appendix

    1. ENTEROME
    2. SERES THERAPEUTICS
    3. 4D PHARMA PLC
    4. EVELO BIOSCIENCES, INC
    5. OPTIBIOTIX HEALTH PLC
    6. SYNLOGIC
    7. SECOND GENOME
    8. VEDANTA BIOSCIENCES, INC
    9. FERRING PHARMACEUTICALS
    10. VITHERA PHARMACEUTICALS, INC